The Teaching Vaccine Economics Everywhere (TVEE) training workshop will now be available online and is open to participants free-of-charge. Health economists from universities around the world have developed an online course to strengthen skills related to economics and financing of national immunization programs and to improve the sustainability of vaccine delivery in low and middle-income … Continued
Focus Area: Evaluating cost and cost-effectiveness of immunization programs
Results 1 -10 of 28
Assessing the Incremental Costs and Savings of Introducing Electronic Immunization Registries and Stock Management Systems: Evidence from the Better Immunization Data Initiative in Tanzania and Zambia
Introduction: poor data quality and use have been identified as key challenges that negatively impact immunization programs in low- and middle-income countries (LMICs). In addition, many LMICs have a shortage of health personnel, and staff available have demanding workloads across several health programs. In order to address these challenges, the Better Immunization Data (BID) Initiative introduced a comprehensive suite of interventions,
… ContinuedNew Evidence Shows Investments in Vaccination Produce Even Greater Returns than Previously Thought
This article originally appeared on Gavi’s website. The Decade of Vaccine Economics (DoVE) Project, carried out by the Johns Hopkins Bloomberg School of Public Health’s International Vaccine Access Center (IVAC) for nearly ten years, has computed the return-on-investment for vaccines preventing ten infectious diseases in 94 low- and middle-income countries, including 73 countries that have received support from … Continued
Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011–30
ABSTRACT
Estimating the value of global investment in immunization programs is critical to helping decision makers plan and mobilize immunization programs and allocate resources required to realize their full benefits. We estimated economic benefits using cost-of-illness and value-of-a-statistical-life approaches and combined this estimation with immunization program costs to derive the return on investment from immunization programs against ten pathogens for ninety-four low- and middle-income countries for the period 2011–30.
… ContinuedImmunization Delivery Cost Catalogue (IDCC)
The Immunization Delivery Cost Catalogue (IDCC) is the most comprehensive, current, and standardized global evidence on the cost of delivering vaccines. In January 2017 and again in April 2018 and December 2019, ThinkWell completed a systematic review of the current evidence base on immunization delivery costs (IDC)*. The IDCC was built to answer a question frequently asked by national and global immunization stakeholders: “What are the unit costs of vaccine delivery across different LMICs and through a variety of delivery strategies?”
… ContinuedTeaching Vaccine Economics Everywhere (TVEE) Course Materials
1. Health Economics for Vaccines
The process of creating vaccines, manufacturing, distributing, and injecting them into individuals is a complex process requiring multiple decisions by multiple groups and individuals. On the supply side there are pharmaceutical companies, regulatory authorities, distributors, and thousands of health care workers who have to make strategic choices.
… ContinuedProVac Toolkit: Providing Tools to Support Vaccine Decision Making at Country-level
PAHO’s ProVac Initiative helps national immunization programs managers and policymakers make more robust, evidence based decisions. Since 2004, the ProVac Initiative and its collaborators have trained hundreds of people at ministries of health in the Americas and elsewhere on the development and use of vaccine impact, cost and cost-effectiveness data to inform decision making. More than 30 countries have received direct technical assistance to conduct cost or cost-effectiveness analyses on immunization programs from the Initiative.
… ContinuedPapillomavirus Rapid Interface for Modelling and Economics (PRIME) Tool
The spreadsheet-based PRIME tool is intended for in-country analysts (not necessarily economists) who are advising national governments on HPV vaccine introduction.
PRIME is designed to give users an idea of:
-
- The magnitude of the burden of cervical cancer
- The impact of introducing HPV vaccination for girls prior to sexual debut
- Healthcare costs incurred as a result of cervical cancer treatment
- Costs associated with vaccination
- Long-term savings which may result from a vaccination program
The tool is intended for use by non-modeller users such as country program managers and planners and decision makers in low- and middle income countries.
… ContinuedTeaching Vaccine Economics Everywhere (TVEE) Capacity Building Training in Vaccine Economics
02/11/2020
The Teaching Vaccine Economics Everywhere (TVEE) project announces the launch of the first workshops of the series in Bangkok, Thailand. The workshop series focuses on capacity building in applied vaccine economics, cost-effectiveness and finance. The workshop series will be held at the Faculty of Pharmacy in Mahidol University, and will cover topics in Vaccine Economics, … Continued
Re-evaluating the Potential Impact and Cost-effectiveness of Rotavirus Vaccination in 73 Gavi Countries: A Modelling Study
Background
Previous studies have found rotavirus vaccination to be highly cost-effective in low-income countries. However, updated evidence is now available for several inputs (ie, rotavirus disease mortality rates, rotavirus age distributions, vaccine timeliness, and vaccine efficacy by duration of follow-up), new rotavirus vaccines have entered the market, vaccine prices have decreased, and cost-effectiveness thresholds have been re-examined. We aimed to provide updated cost-effectiveness estimates to inform national decisions about the new introduction and current use of rotavirus vaccines in Gavi countries. … Continued